Faculty profile
David Palma
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?
International journal of radiation oncology, biology, physics · 2010
Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer.
International journal of radiation oncology, biology, physics · 2009
Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy.
International journal of radiation oncology, biology, physics · 2008 · first author
Latest funding
- $9,980
Future of Stereotactic Ablative Radiotherapy (SABR) Trials in Oligometastatic Cancer: Continuing Canadian-Led International Investigations in Radiation Therapy
CIHR · 2022 · Principal investigator
- $699,380
A phase III randomized controlled trial and economic evaluation of Stereotactic Ablative Radiotherapy (SABR) for Comprehensive treatment of OligoMETastatic (1-3 metastases) cancer: SABR-COMET-3
CIHR · 2019 · Principal investigator
6 publications.
Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?
Thompson A, Keyes M, Pickles T, Palma D, Moravan V, Spadinger I, Lapointe V, Morris WJ
Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer.
Morris WJ, Keyes M, Palma D, McKenzie M, Spadinger I, Agranovich A, Pickles T, Liu M, Kwan W, Wu J, Lapointe V, Berthelet E, Pai H, Harrison R, Kwa W, Bucci J, Racz V, Woods R
Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy.
Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, McKenzie M, Morris J, Otto K
Pretreatment prostate-specific antigen velocity is associated with development of distant metastases and prostate cancer mortality in men treated with radiotherapy and androgen-deprivation therapy.
Palma D, Tyldesley S, Pickles T, Prostate Cohort Outcomes Initiative
Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer.
Palma D, Pickles T, Tyldesley S, Prostate Cohort Outcomes Initiative
Pretreatment PSA velocity as a predictor of disease outcome following radical radiation therapy.
Palma D, Tyldesley S, Blood P, Liu M, Morris J, Pickles T, Prostate Cohort Outcomes Initiative
Future of Stereotactic Ablative Radiotherapy (SABR) Trials in Oligometastatic Cancer: Continuing Canadian-Led International Investigations in Radiation Therapy
Principal investigators: Olson, Robert A; Schellenberg, Devin; Palma, David
Keywords: Cancer; Clinical Trials; Metastases; Oligometastases; Radiation Oncology; Stereotactic Ablative Radiotherapy
A phase III randomized controlled trial and economic evaluation of Stereotactic Ablative Radiotherapy (SABR) for Comprehensive treatment of OligoMETastatic (1-3 metastases) cancer: SABR-COMET-3
Principal investigators: Olson, Robert A; Allan, Alison L; Palma, David; Peacock, Stuart J; Tyldesley, Scott K
Keywords: Biomarkers; Cost-Effectiveness/Cost-Utility; Metastatic Cancers; Oligometastatic Disease/State; Overall Survival; Progression-Free Survival; Quality Of Life; Quality-Adjusted Life Years; Stereotactic Radiotherapy; Toxicity
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Radiation Oncology
- Audiology and Speech Science
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.